Cargando…
The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice
AIMS: Bindarit is an original compound with peculiar anti-inflammatory activity due to a selective inhibition of a subfamily of inflammatory chemokines, including the monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7, and MCP-2/CCL8. In this study, we investigated the effect of bindarit on neoint...
Autores principales: | Grassia, Gianluca, Maddaluno, Marcella, Guglielmotti, Angelo, Mangano, Giorgina, Biondi, Giuseppe, Maffia, Pasquale, Ialenti, Armando |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777949/ https://www.ncbi.nlm.nih.gov/pubmed/19592568 http://dx.doi.org/10.1093/cvr/cvp238 |
Ejemplares similares
-
Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching
por: Maddaluno, Marcella, et al.
Publicado: (2012) -
Murine Aortic Smooth Muscle Cells Acquire, Though Fail to Present Exogenous Protein Antigens on Major Histocompatibility Complex Class II Molecules
por: Maddaluno, Marcella, et al.
Publicado: (2014) -
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
por: Ge, Shujun, et al.
Publicado: (2012) -
Macrophage Autophagy in Atherosclerosis
por: Maiuri, Maria Chiara, et al.
Publicado: (2013) -
Perivascular mast cells regulate vein graft neointimal formation and remodeling
por: Wu, Junxi, et al.
Publicado: (2015)